BU-NOT-SET

CONTACT US
Overcoming technical transfer challenges in virotherapy manufacturing
  • Biologics
virotherapy
Insight
Flexibility in gene therapy: Adapting to the unique gene therapy demands
  • Biologics
gene therapy
eBook
Webinar: An optimised Plasmid DNA platform
  • Biologics
Plasmid DNA
Webinar
The future of oral solid dose formulations
  • Drug substance
  • Industry trends
oral solid dose
Insight
Trends and challenges to impact the OSD space in 2024 and beyond
  • Industry trends
OSD
Insight
Shaping pharma's carbon-reduced future
  • Sustainability
Sustainability
Insight
Focus on sustainability: Saving water in Bengaluru
  • Sustainability
Clouds
Insight
Safe handling of highly potent active pharmaceutical ingredients
  • Drug product
  • Drug substance
Safe handling
Insight
Development and validation of ICP-OES for trace element estimation
  • Analytical chemistry
oral solid dose
White paper
Fact sheet
  • Analytical chemistry
Nitrosamines analysis
Insight
  • Biologics
  • Drug substance
Enabling oral solid dosage form delivery of biologics
Fact sheet
  • Biologics
Plasmid DNA manufacturing capabilities
Insight
  • Analytical chemistry
  • Drug substance
Leveraging analytics throughout development and manufacture to achieve commercial success
Insight
  • Sustainability
2,300 solar panels installed at Recipharm’s Holmes Chapel
White paper
  • Analytical chemistry
  • Drug substance
Analysing prebiotic oligosaccharides for future product innovation
Insight
  • Industry trends
  • Manufacturing
Enhancing sterile processing for future vaccine programs
Insight
  • Sustainability
Increasing carbon emission transparency through SBTi contributions
Insight
  • Biologics
Single-use technologies are enabling increasing demand for biologics